Canadian regulators warn on medical marijuana disclosures

February 23, 2015 4:35 PM

15 0

TORONTO (Reuters) - Companies rushing to enter Canada's fledgling medical marijuana sector have not adequately disclosed potential business risks to investors, Canadian securities regulators said on Monday.

A review by the umbrella Canadian Securities Administrators (CSA) group found "unbalanced and promotional disclosure that often promoted the benefits, but failed to outline the risks involved," CSA head Bill Rice said.

Read more

To category page